Rhode Island Mood & Memory Research Institute

Rhode Island Mood & Memory Research Institute We specialize in Alzheimer's Disease Research.

Rhode Island Mood & Memory Research Institute (RIMMRI) is always looking for new patients to help further the development of new medications. Rhode Island Mood & Memory Research Institute (RIMMRI) brings
together patients, researchers, and sponsors, facilitating the
development and study of cutting edge medical treatments. RIMMRI
specializes in Central Nervous System (CNS) clinical trials which
include Alzheimer's Disease, Insomnia and Depression clinical studies

Call 401-435-8950 for more information about this trial.
04/15/2025

Call 401-435-8950 for more information about this trial.

04/15/2025

Do you support a loved one with Alzheimer’s Disease? They may be able to join a clinical trial aimed at improving memory and thinking. If they are aged 50 or older, their participation may provide valuable insights and aid in the discovery of innovative treatments. Together, we can understand Alzheimer's better. Help them check if they are eligible!
Please call 401-435-8950 for more information.

This trial is testing a new potential treatment for people diagnosed with Alzheimer's disease. We want to see if it's safe, tolerable, and can help with memory and cognition problems.

04/09/2025

Caring for someone with Alzheimer’s Disease? If your loved one is 50 years or older and has
mild or moderate Alzheimer’s Disease, they may be eligible for a clinical trial testing a new
potential treatment designed to improve thinking and memory. This may help advance
Alzheimer’s research and discover new treatment

This trial is testing a new potential treatment for people diagnosed with Alzheimer's disease. We want to see if it's safe, tolerable, and can help with memory and cognition problems.

04/09/2025

Make an impact in the understanding of Alzheimer’s Disease by joining a clinical trial. If you are 50 years or older and have a diagnosis of mild or moderate Alzheimer’s disease, your
participation may help researchers develop new treatments and improve existing ones. This trial is testing a new potential treatment designed to improve memory and thinking. Be a part of the community striving for breakthroughs in Alzheimer’s Disease care. Every volunteer brings us one step closer to treatments that make a real impact. Sign up and help shape the future of Alzheimer’s Disease treatment. Please call 401-435-8950 for more information.

03/25/2025

It may be time to consider a Clinical Trial if you or a loved one have been diagnosed with Mild to Moderate Alzheimer's Disease.
To qualify participants must be:
• At least 50 years old
• Be in general good health
• Have a study partner that is able to attend all study visits.
If eligible participants will receive:
• Study related medical care
• Daily oral study medication
• Compensation for time and travel.
Please call Annie or Lynn at 401-435-8950 or email Annie at acerullo@rimmri.com or Lynn at lrainville@rimmri.com at Rhode Island Mood & Memory Research Institute.

Address

1018 Waterman Ave
East Providence, RI
02914

Opening Hours

Monday 8:30am - 5pm
Tuesday 8:30am - 5pm
Wednesday 8:30am - 5pm
Thursday 8:30am - 5pm
Friday 8:30am - 5pm

Telephone

+14014358950

Alerts

Be the first to know and let us send you an email when Rhode Island Mood & Memory Research Institute posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Rhode Island Mood & Memory Research Institute:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

The staff at Rhode Island Mood and Memory Research Institute (RIMMRI) has been actively involved in clinical research trials for the treatment and prevention of Alzheimer’s disease for over twenty years. Over that time we have established an international reputation with the pharmaceutical industry as being a leader in quality patient care, retention and data collection. We have participated in the pivotal trials that have brought all the currently approved medications to treat Alzheimer’s disease symptoms to market. Today we are actively involved in cutting edge research to slow the progression of Alzheimer’s disease in its earliest stages.